azacitidine has been researched along with raltegravir potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, R; Chen, X; Jabri, S; Jin, H; Kim, CU; Lansdown, R; Metobo, S; Mish, M; Pastor, R; Pyun, P; Tsiang, M; Wright, M | 1 |
| Clouser, CL; Greggs, WM; Mansky, LM; Patterson, SE | 1 |
2 other study(ies) available for azacitidine and raltegravir potassium
| Article | Year |
|---|---|
Tricyclic HIV integrase inhibitors: potent and orally bioavailable C5-aza analogs.
Topics: Administration, Oral; Animals; Azacitidine; Biological Availability; Crystallography, X-Ray; Dogs; HIV Integrase Inhibitors; Humans; Organic Chemicals; Pyrrolidinones; Raltegravir Potassium; Rats | 2008 |
Discovery of drugs that possess activity against feline leukemia virus.
Topics: Adenine; Animals; Antiviral Agents; Azacitidine; Cat Diseases; Cats; Decitabine; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Leukemia Virus, Feline; Leukemia, Feline; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Retroviridae Infections; Tenofovir; Tumor Virus Infections | 2012 |